Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zila Bioworks is an industrial biotechnology company focused on developing sustainable, bio-based alternatives to petroleum-derived chemicals. The company's flagship technology is a patented bio-epoxy resin derived from industrial hemp oil, designed to replace toxic bisphenol A (BPA) and epichlorohydrin in various manufacturing applications. Zila's products target high-performance sectors including wind energy, sporting goods, and floor coatings, offering a significantly lower carbon footprint compared to traditional resins. By leveraging plant-based feedstocks, Zila Bioworks aims to decarbonize the chemical industry while maintaining the structural integrity and performance required for industrial-grade composites.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zila Bioworks.